ZW13587A1 - Pharmaceutical formulations - Google Patents
Pharmaceutical formulationsInfo
- Publication number
- ZW13587A1 ZW13587A1 ZW135/87A ZW13587A ZW13587A1 ZW 13587 A1 ZW13587 A1 ZW 13587A1 ZW 135/87 A ZW135/87 A ZW 135/87A ZW 13587 A ZW13587 A ZW 13587A ZW 13587 A1 ZW13587 A1 ZW 13587A1
- Authority
- ZW
- Zimbabwe
- Prior art keywords
- pharmaceutical formulations
- formulations
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868618847A GB8618847D0 (en) | 1986-08-01 | 1986-08-01 | Pharmaceutical formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
ZW13587A1 true ZW13587A1 (en) | 1989-02-15 |
Family
ID=10602097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZW135/87A ZW13587A1 (en) | 1986-08-01 | 1987-07-22 | Pharmaceutical formulations |
Country Status (22)
Country | Link |
---|---|
US (1) | US4996222A (fr) |
EP (1) | EP0257823B1 (fr) |
JP (1) | JPH0643304B2 (fr) |
KR (1) | KR960012397B1 (fr) |
CN (1) | CN1024497C (fr) |
AU (1) | AU601206B2 (fr) |
CA (1) | CA1287802C (fr) |
DE (1) | DE3778795D1 (fr) |
DK (1) | DK149988D0 (fr) |
EG (1) | EG18388A (fr) |
ES (1) | ES2037086T3 (fr) |
GB (1) | GB8618847D0 (fr) |
GR (1) | GR3005298T3 (fr) |
HU (1) | HU205853B (fr) |
IE (1) | IE60759B1 (fr) |
IL (1) | IL83349A (fr) |
MY (1) | MY100998A (fr) |
PH (1) | PH23505A (fr) |
PT (1) | PT85468B (fr) |
WO (1) | WO1988000825A1 (fr) |
ZA (1) | ZA875631B (fr) |
ZW (1) | ZW13587A1 (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU196775B (en) * | 1986-08-05 | 1989-01-30 | Richter Gedeon Vegyeszet | Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances |
NZ230701A (en) * | 1988-09-20 | 1992-01-29 | Glaxo Group Ltd | Pharmaceutical compositions comprising ranitidine, alginic acid and a carbonate or bicarbonate |
GB9127150D0 (en) * | 1991-12-20 | 1992-02-19 | Smithkline Beecham Plc | Novel treatment |
US5272137A (en) * | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
FI941777A (fi) * | 1993-04-16 | 1994-10-17 | Mcneil Ppc Inc | Vesipitoinen farmaseuttinen suspensio ja menetelmä sen valmistamiseksi |
AU3154895A (en) * | 1994-08-01 | 1996-03-04 | Kv Pharmaceutical Corporation | Tastemasked liquid pharmaceutical delivery system |
GB2298365B (en) * | 1995-03-03 | 1997-05-07 | Reckitt & Colmann Prod Ltd | A liquid pharmaceutical composition alginate and potassium bicarbonate |
GB9504599D0 (en) * | 1995-03-03 | 1995-04-26 | Reckitt & Colmann Prod Ltd | Improvements in or relating to organic compositions |
US6395307B1 (en) * | 1997-04-30 | 2002-05-28 | Reckitt Benckiser (Uk) Limited | Pourable alginate compositions |
GB9708772D0 (en) * | 1997-04-30 | 1997-06-25 | Reckitt & Colmann Prod Ltd | Organic compositions |
IN186245B (fr) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
US6287693B1 (en) * | 1998-02-25 | 2001-09-11 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
US6132758A (en) * | 1998-06-01 | 2000-10-17 | Schering Corporation | Stabilized antihistamine syrup |
GB9930058D0 (en) | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
US6515008B1 (en) * | 2000-05-04 | 2003-02-04 | Smithkline Beecham Corporation | Formulation |
DE10224086A1 (de) * | 2002-05-31 | 2003-12-11 | Bayer Ag | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
US6930119B2 (en) * | 2002-07-17 | 2005-08-16 | Reliant Pharmaceuticals, Inc. | Liquid pharmaceutical composition |
WO2004080343A2 (fr) * | 2003-03-10 | 2004-09-23 | The Regents Of The University Of Michigan | Compositions et methodes d'utilisation de produits d'obturation durale a base d'alginate |
EP1811854A1 (fr) * | 2004-11-02 | 2007-08-01 | PURAC Biochem BV | Procede permettant de stabiliser et d'empecher la coagulation de proteines dans le lait |
US20060094760A1 (en) * | 2004-11-04 | 2006-05-04 | Fawzy Abdel A | Composition, system and method of treatment of gastrointestinal disorders with nizatidine oral solution |
ATE396710T1 (de) * | 2005-07-19 | 2008-06-15 | Ethypharm Sa | Gastroretentive zusammensetzungen und verfahren zur herstellung |
FR2911506B1 (fr) * | 2007-01-18 | 2009-07-03 | Ceva Sante Animale Sa | Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees |
US8999395B2 (en) * | 2007-02-09 | 2015-04-07 | Ceva Sante Animale | Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions |
JP2013504569A (ja) * | 2009-09-10 | 2013-02-07 | バイアル−ポルテラ アンド シーエー,エス.エー. | エスリカルバゼピンアセタートの経口懸濁製剤 |
CN111481508A (zh) * | 2016-10-19 | 2020-08-04 | 萨恩帕斯药物有限公司 | 针对引起离子通道病的药物的保护性组合物和方法 |
GB201918617D0 (en) * | 2019-12-17 | 2020-01-29 | Reckitt Benckiser Health Ltd | Personal lubricant composition |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56104868A (en) * | 1980-01-24 | 1981-08-20 | Fujimoto Seiyaku Kk | Conversion between polymorphous crystals of cimetidine |
HU185457B (en) * | 1981-09-25 | 1985-02-28 | Richter Gedeon Vegyeszet | Process for preparating cimetidine-z |
CA1239349A (fr) * | 1983-10-10 | 1988-07-19 | Eberhard F. Gottwald | Compose pharmaceutique contenant de la cimetidine |
-
1986
- 1986-08-01 GB GB868618847A patent/GB8618847D0/en active Pending
-
1987
- 1987-07-22 ZW ZW135/87A patent/ZW13587A1/xx unknown
- 1987-07-27 IL IL83349A patent/IL83349A/xx not_active IP Right Cessation
- 1987-07-27 CA CA000543046A patent/CA1287802C/fr not_active Expired - Lifetime
- 1987-07-27 MY MYPI87001138A patent/MY100998A/en unknown
- 1987-07-28 PH PH35588A patent/PH23505A/en unknown
- 1987-07-29 ES ES198787306731T patent/ES2037086T3/es not_active Expired - Lifetime
- 1987-07-29 HU HU874205A patent/HU205853B/hu unknown
- 1987-07-29 EP EP87306731A patent/EP0257823B1/fr not_active Expired - Lifetime
- 1987-07-29 DE DE8787306731T patent/DE3778795D1/de not_active Expired - Lifetime
- 1987-07-29 JP JP62504716A patent/JPH0643304B2/ja not_active Expired - Lifetime
- 1987-07-29 AU AU77564/87A patent/AU601206B2/en not_active Expired
- 1987-07-29 KR KR1019880700331A patent/KR960012397B1/ko not_active IP Right Cessation
- 1987-07-29 WO PCT/GB1987/000539 patent/WO1988000825A1/fr unknown
- 1987-07-30 EG EG439/87A patent/EG18388A/xx active
- 1987-07-30 ZA ZA875631A patent/ZA875631B/xx unknown
- 1987-07-31 PT PT85468A patent/PT85468B/pt unknown
- 1987-07-31 CN CN87105387A patent/CN1024497C/zh not_active Expired - Lifetime
- 1987-07-31 IE IE207787A patent/IE60759B1/en not_active IP Right Cessation
-
1988
- 1988-03-18 DK DK149988A patent/DK149988D0/da not_active Application Discontinuation
-
1990
- 1990-03-09 US US07/490,851 patent/US4996222A/en not_active Expired - Lifetime
-
1992
- 1992-07-29 GR GR920401630T patent/GR3005298T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT85468A (en) | 1987-08-01 |
DE3778795D1 (de) | 1992-06-11 |
KR880701551A (ko) | 1988-11-03 |
ZA875631B (en) | 1989-03-29 |
GR3005298T3 (fr) | 1993-05-24 |
US4996222A (en) | 1991-02-26 |
IL83349A (en) | 1992-03-29 |
EP0257823A1 (fr) | 1988-03-02 |
DK149988A (da) | 1988-03-18 |
CN87105387A (zh) | 1988-02-17 |
AU7756487A (en) | 1988-02-24 |
WO1988000825A1 (fr) | 1988-02-11 |
HU205853B (en) | 1992-07-28 |
JPH01500434A (ja) | 1989-02-16 |
HUT46541A (en) | 1988-11-28 |
EP0257823B1 (fr) | 1992-05-06 |
EG18388A (en) | 1992-10-30 |
ES2037086T3 (es) | 1993-06-16 |
KR960012397B1 (ko) | 1996-09-20 |
MY100998A (en) | 1991-06-29 |
CA1287802C (fr) | 1991-08-20 |
JPH0643304B2 (ja) | 1994-06-08 |
IE872077L (en) | 1988-02-01 |
AU601206B2 (en) | 1990-09-06 |
IE60759B1 (en) | 1994-08-10 |
CN1024497C (zh) | 1994-05-18 |
DK149988D0 (da) | 1988-03-18 |
PH23505A (en) | 1989-08-16 |
PT85468B (pt) | 1990-06-29 |
GB8618847D0 (en) | 1986-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2196964B (en) | Pharmaceutical compositions | |
GB8610572D0 (en) | Pharmaceutical preparation | |
GB8716904D0 (en) | Stable pharmaceutical preparation | |
GB8618847D0 (en) | Pharmaceutical formulations | |
GB8608818D0 (en) | Pharmaceutical compositions | |
CS8700282A2 (en) | Nicorandil-containing stable pharmaceutical | |
GB2191696B (en) | Pharmaceutical compositions | |
GB2190838B (en) | Pharmaceutical compositions | |
GB2187953B (en) | Pharmaceutical formulation | |
GB8623389D0 (en) | Pharmaceutical formulations | |
GB2188235B (en) | Pharmaceutical compositions | |
GB8721313D0 (en) | Pharmaceutical preparation | |
ZA876048B (en) | Pharmaceutical formulation | |
GR871915B (en) | Pharmaceutical formulations | |
ZA876959B (en) | Pharmaceutical formulations | |
GB8603097D0 (en) | Pharmaceutical formulations | |
GB8503221D0 (en) | Pharmaceutical formulations | |
GB8707419D0 (en) | Pharmaceutical formulations | |
GB8707417D0 (en) | Pharmaceutical formulations | |
GB8704774D0 (en) | Pharmaceutical formulations | |
GB8707418D0 (en) | Pharmaceutical formulations | |
GB8707420D0 (en) | Pharmaceutical formulations | |
GB8723862D0 (en) | Pharmaceutical formulations | |
GB8708527D0 (en) | Pharmaceutical formulations | |
GB8720485D0 (en) | Pharmaceutical formulations |